← 返回

黏膜相关恒定 T 细胞的重编程与再分化揭示其抑瘤活性

英文原题:Reprogramming and redifferentiation of mucosal-associated invariant T cells reveal tumor inhibitory activity.

查看英文原题

Reprogramming and redifferentiation of mucosal-associated invariant T cells reveal tumor inhibitory activity.

PubMed 2022/04/05(内容时间) Elife N/A(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

黏膜相关恒定T(MAIT)细胞属于先天样T细胞家族,连接先天免疫与适应性免疫。尽管MAIT细胞已被认为与肿瘤免疫有关,但目前仍不清楚其发挥促肿瘤还是抑肿瘤细胞的作用。

因此,我们在此采用诱导多能干细胞(iPSC)技术来研究这一问题。将小鼠MAIT细胞重编程为iPSC,并再分化为MAIT样细胞(m-reMAIT细胞)。m-reMAIT细胞在存在和不存在抗原呈递细胞以及MR1-四聚体(一种检测MAIT细胞的试剂)的情况下被激动剂激活。这种激活伴随蛋白酪氨酸磷酸化以及辅助性T(Th)1、Th2和Th17细胞因子和炎性趋化因子的产生。过继转移后,m-reMAIT细胞在小鼠体内成熟并迁移至不同器官。

此外,m-reMAIT细胞在肺转移模型中抑制肿瘤生长,并通过NK细胞介导的溶细胞活性增强,在肿瘤接种后延长小鼠生存期。总之,本研究结果证明了m-reMAIT细胞在肿瘤免疫中的效用和作用,并为MAIT细胞在免疫中的功能提供了见解。

展开英文摘要原文

Mucosal-associated invariant T (MAIT) cells belong to a family of innate-like T cells that bridge innate and adaptive immunities. Although MAIT cells have been implicated in tumor immunity, it currently remains unclear whether they function as tumor-promoting or inhibitory cells.

Therefore, we herein used induced pluripotent stem cell (iPSC) technology to investigate this issue. Murine MAIT cells were reprogrammed into iPSCs and redifferentiated towards MAIT-like cells (m-reMAIT cells). m-reMAIT cells were activated by an agonist in the presence and absence of antigen-presenting cells and MR1-tetramer, a reagent to detect MAIT cells.

This activation accompanied protein tyrosine phosphorylation and the production of T helper (Th)1, Th2, and Th17 cytokines and inflammatory chemokines. Upon adoptive transfer, m-reMAIT cells migrated to different organs with maturation in mice.

Furthermore, m-reMAIT cells inhibited tumor growth in the lung metastasis model and prolonged mouse survival upon tumor inoculation through the NK cell-mediated reinforcement of cytolytic activity. Collectively, the present results demonstrated the utility and role of m-reMAIT cells in tumor immunity and provide insights into the function of MAIT cells in immunity.

论文信息

作者
Sugimoto C、Murakami Y、Ishii E、Fujita H、Wakao H
单位
Host Defense Division, Research Center for Advanced Medical Science, Dokkyo Medical University, Mibu, Japan.Japan
文献类型
非美国政府资助研究
期刊
eLife2022 Apr 5
原文标识
PubMed 35379387 · DOI 10.7554/eLife.70848